Cellectis S.A. Releases Interim Financial Results
Company Announcements

Cellectis S.A. Releases Interim Financial Results

Cellectis SA (CLLS) has released an update.

Cellectis S.A. has released its unaudited financial statements for the three and nine months ending September 30, 2024, highlighting its adherence to international accounting standards. The report reflects the company’s financial position in U.S. dollars, showcasing its assets and liabilities. Investors should note the potential risks and uncertainties impacting the company’s future financial performance.

For further insights into CLLS stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskCellectis SA Advances CAR T-cell Therapy for Solid Tumors
TheFlyCellectis price target lowered to $5 from $7 at Barclays
TheFlyCellectis reports Q3 EPS (22c), consensus (21c)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App